MedTrace Logo

Specific Autoantibody Testing in Patients With Interstitial Lung Disease

NCT01600352 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2017-11-08

No results posted yet for this study

Summary

The purpose of this study is to evaluate the clinical utility of specific autoantibody testing in unmasking an underlying connective tissue disorder in patients who present with interstitial lung disease and found to have weak positive ANA (1:400 titre) with no overt connective tissue disease manifestations OR borderline/negative ANA with some clinical suggestion of connective tissue disease.

Conditions

Sponsors & Collaborators

  • Singapore General Hospital

    lead OTHER

Principal Investigators

  • Su Ying Low, BMBCh · Singapore General Hospital

Eligibility

Min Age
21 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2017-04-30
Completion
2017-04-30

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01600352 on ClinicalTrials.gov